AFYREN
Christophe Calice is an accomplished executive with extensive experience in leadership and investment roles. Since January 2011, Christophe has served as CEO of ECILAC CAPITAL and has led XL2C INVEST as CEO since November 2013, which operates as a financial holding company. Additionally, Christophe has been the CEO of AFY PARTNERS since December 2016, acting as the principal shareholder of AFYREN. Other notable positions include Board Member at AFYREN since December 2018 and various investment roles in companies such as SNS 69, #biotyfood, Fulllife - Gameswear Company, Quest Education Group, NeoMedLight, and La Villa Rose.
This person is not in any teams
AFYREN
AFYREN develop innovation in biotechnologies for the valorization of non-food biomass and in respect of the environment.